ACVC Premium Access

Coronary angioplasty and COVID-19: are heparin requirements and thrombotic complications increasing?

Topic: Percutaneous Coronary Intervention (PCI)

Congress Presentation

About the speaker

Miss Hannah Crane

St Bartholomews and Queen Mary University, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

7 more presentations in this session

Trends in major bleeding events in patients with acute coronary syndrome.

Speaker: Doctor A. Cordero (Elche, ES)


Long-term ischemic and bleeding risk with extended dual antiplatelet therapy after PCI in patients with 2018 ESC/EACTS myocardial revascularization guideline-endorsed high thrombotic risk features.

Speaker: Doctor H. Wang (Beijing, CN)


Safety and efficacy of direct oral anticoagulants (DOACs) vs warfarin in patients with concurrent atrial fibrillation and bioprosthetic mitral or aortic valve replacement-a meta analysis

Speaker: Ms A. Abdul Razzack (Vijayawada, IN)


Cardiovascular outcomes of clopidogrel and aspirin vs ticagrelor and aspirin in geriatric population with acute coronary syndrome-a systematic review and meta analysis

Speaker: Ms A. Abdul Razzack (Vijayawada, IN)


Benefit and Harm of Extended Dual Antiplatelet Therapy After PCI in high-risk TWILIGHT-like patients with acute coronary syndrome

Speaker: Doctor H. Wang (Beijing, CN)


Access the full session

Live Abstract session - Antithrombotics and bleeding

Speakers: Miss H. Crane, Doctor A. Cordero, Doctor H. Wang, Ms A. Abdul Razzack, Ms A. Abdul Razzack...

About the event


ACVC 2021

13 March - 14 March 2021

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb